Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
SUM225CWN
HER2amp
Basal A
Methotrexate
DHFR
Metabolism
7533.084
uM
inf
inf
0.9294 0.9294 0.0000 -0.0224
0.2330
1.0396
MB 157
Unknown
Unknown
PS-1145
IKK
NFKB
7482.065
uM
inf
inf
0.9413 0.9413 0.0000 0.0141
0.0523
2.2390
HCC70
TNBC
Basal A
PD 98059
MEK
MAPK
12400.152
uM
inf
inf
0.7537 0.7537 0.0000 0.0534
-0.0064
1.1392
HCC3153
TNBC
Basal A
AG1478
EGFR
ErbB
7853.016
uM
inf
inf
0.9101 0.9101 0.0000 0.0481
0.4996
1.6178
CAMA-1
HR+
Luminal
PD184352
MEK
MAPK
10755.146
uM
inf
inf
0.7200 0.7200 0.0000 0.1412
0.2466
0.8035
HCC1395
TNBC
Basal B
Epirubicin
TOP2
TOP
7816.017
uM
inf
inf
0.6386 0.6386 0.0000 0.2394
0.3980
1.2318
HCC1143
TNBC
Basal A
Chloroquine
13099.177
uM
inf
inf
-0.9999 -0.9999 0.0000 0.7050
0.1850
0.7419
SUM225CWN
HER2amp
Basal A
Nilotinib
ABL
nRTK
10579.145
uM
inf
inf
0.7382 0.7382 0.0000 0.1219
0.2766
1.0664
SUM225CWN
HER2amp
Basal A
Nilotinib
ABL
nRTK
12098.145
uM
inf
inf
0.9374 0.9374 0.0000 0.0259
0.3617
0.9769
MCF7
HR+
Luminal
PD184352
MEK
MAPK
10997.155
uM
inf
inf
0.9516 0.9516 0.0000 -0.0284
-0.8847
1.3159
MDA-MB-415
HR+
Luminal
ZM-447439
AURK
AURK
10938.15
uM
inf
inf
0.5380 0.5380 0.0000 0.3086
-0.0630
1.0480
MDA-MB-361
HER2amp
Luminal
NU6102
CDK1/2
CDK
12379.147
uM
inf
inf
-1.0000 -1.0000 0.0000 0.2178
0.2648
0.3192
MDA-MB-361
HER2amp
Luminal
Gefitinib
EGFR
ErbB
9648.132
uM
inf
inf
0.2751 0.2751 0.0000 0.2918
0.2312
0.7147
MCF 10F
NM
-
(Z)-4-Hydroxytamoxifen
ESR1
7488.016
uM
inf
inf
0.7328 0.7328 0.0000 0.0898
0.5484
1.2238
Hs 578T
TNBC
Basal B
AG1024
IGF1R
RTK
7474.066
uM
inf
inf
1.0500 1.0500 0.0000 0.0000
-0.0022
2.7948
HCC38
TNBC
Basal B
Cetuximab
EGFR
ErbB
7854.018
uM
inf
inf
0.7802 0.7802 0.0000 0.1098
0.010
1.2298
MDA-MB-361
HER2amp
Luminal
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7507.094
uM
inf
inf
0.0352 0.0352 0.0000 0.6740
0.2984
1.0418
HCC1395
TNBC
Basal B
FTase Inhibitor I
Ftase
MAPK
12000.167
uM
inf
inf
0.7814 0.7814 0.0000 0.1511
-0.0746
0.7185
HCC1395
TNBC
Basal B
FTase Inhibitor I
Ftase
MAPK
12084.154
uM
inf
inf
0.7715 0.7715 0.0000 0.1395
-0.0309
1.2963
BT-474
HER2amp
Luminal
ZM-447439
AURK
AURK
12178.16
uM
inf
inf
0.5577 0.5577 0.0000 0.3142
0.4077
0.7392
SUM225CWN
HER2amp
Basal A
PD184352
MEK
MAPK
12098.155
uM
inf
inf
0.7400 0.7400 0.0000 0.1295
0.3373
1.0503
SUM225CWN
HER2amp
Basal A
PD184352
MEK
MAPK
12098.155
uM
inf
inf
0.7400 0.7400 0.0000 0.1295
0.3373
1.0503
SUM225CWN
HER2amp
Basal A
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7533.095
uM
inf
inf
0.7658 0.7658 0.0000 0.0600
0.0756
0.9850
SUM225CWN
HER2amp
Basal A
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7534.095
uM
inf
inf
0.8515 0.8515 0.0000 0.0060
0.2793
0.8052
SUM225CWN
HER2amp
Basal A
PS-1145
IKK
NFKB
7534.065
uM
inf
inf
0.8726 0.8726 0.0000 -0.0301
0.3917
0.9529